title: Which transarterial therapy is best for hepatocellular carcinoma?--the evidence to date.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Tsochatzis
authors.forename: Tim
authors.initials: T
authors.lastname: Meyer
authors.forename: Laura
authors.initials: L
authors.lastname: Marelli
authors.forename: Andrew K
authors.initials: AK
authors.lastname: Burroughs
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D004621:Embolization, Therapeutic / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents